Classification of liver incidents occurring during antitubercular treatments which include rifampicin
Blanchon, P.; Paillas, J.; Groseille, Y.; Holler, A.; Blanchon, F.
Annales de Medecine Interne 125(12): 919-922
1974
ISSN/ISBN: 0003-410X PMID: 4469954 Document Number: 76389
Document emailed within 1 workday
Related Documents
Zyczyński, T. 1972: Rifampicin: a new antitubercular agent Wiadomosci Lekarskie 25(3): 251-254Favez, G. 1970: A new antitubercular agent: rifampicin Schweizerische Rundschau für Medizin Praxis 59(8): 296-297
Ginzburg, T.S.; Drabkina, R.O. 1972: Antitubercular activity and pharmacokinetics of rifampicin Antibiotiki 17(7): 607-611
Almansa de Cara, S. 1972: Maximum therapeutic efficiency of a guternary antitubercular preparation. (Streptomycin-ethambutol-rifampicin-isoniazid) Revista Clinica Espanola 125(4): 353-356
Rossolini, A.; Cellesi, C.; Debolini, A. 1973: Experimental study of liver damage due to rifampicin and rifampicin-isoniazid combination Il Farmaco; Edizione Pratica 28(6): 345-355
Richard, C.; Quevauvilliers, J. 1983: Acute adrenal insufficiency induced by antitubercular treatment in an addisonian woman. Possible role of the rifampicin-isoniazid combination Presse Medicale 12(12): 767-768
M'iasnykov, V.H. 1993: Acute hepatorenal failure occurring after taking rifampicin Likars'ka Sprava 7: 124-126
Bitaudeau, P.; Clément, S.; Chartier, J.P.; Papapietro, P.M.; Bonnafoux, A.; Arnaud, M.; Trèves, R.; Desproges-Gotteron, R. 1989: Interaction of rifampicin and prednisolone. Apropos of 2 cases occurring in Horton's disease Revue du Rhumatisme et des Maladies Osteo-Articulaires 56(1): 87-88
Delepierre, F.; Rullière, R.; Coury, C. 1971: Lupus and related syndromes: rare complication of long treatments with isoniazid and other antitubercular drugs (apropos of 2 new cases) Revue de Tuberculose et de Pneumologie 35(4): 397-412
Murgoci, G. 1989: Coma--accidental poisoning occurring in the isoniazid + rifampicin treatment of a 7-year-old child Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 38(2): 149-156
Soga, G.; Blanc, L.; Alfa, C.; Grosset, J.; Xavier, S. 1986: Combined treatments consisting of rifampicin in periodic doses: the experience in Niger Acta Leprologica 4(4): 397-407
Janowiec, M.; Zwolska-Kwiek, Z.; Wiśniewska, A.; Wróblewska, H. 1977: Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli Pneumonologia Polska 45(6): 425-430
Pattyn, S.R.; Husser, J.A.; Saint-André, P. 1986: Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy Acta Leprologica 4(4): 445-446
Mergelsberg, M.; Weber, M.; Musch, E. 1990: Change in liver size caused by antitubercular combination therapy Pneumologie 44(6): 806-814
Katikova, O.I.; Kostin, I.V. 2002: Efficacy of galstena in liver damage induced by antitubercular agents Eksperimental'naia i Klinicheskaia Farmakologiia 65(2): 64-66
Austerhoff, A.; Knop, P.; Brennecke, F.G.; Kindler, U.; Scholten, T.; Knieriem, H.J. 1973: Liver toxicity of rifampicin Die Medizinische Welt 24(17): 695-696
Kozma, D.; Tompa, A.; Schaff, Z.; Lapis, K. 1982: The effect of rifampicin and INH on the mouse liver Praxis und Klinik der Pneumologie 36(10): 429-433
Rai, R.; Tripathi, V.D.; Rangare, V.; Reddy, D.S.; Patel, P. 2012: Isolated tubercular liver abscess in an elderly diabetic successfully treated with systemic antitubercular drugs JPMA. Journal of the Pakistan Medical Association 62(2): 170-172
Waisser, K.; Celadník, M.; Sova, J.; Palát, K. 1975: Antitubercular agents. XVI. use of HMO computations in the study of structure-activity relationship of antitubercular agents. IIi Ceskoslovenska Farmacie 24(10): 423-426
Kozma, D.; Mihalik, P. 1984: Liver and kidney damage in rifampicin and ethambutol treatment Zeitschrift für Erkrankungen der Atmungsorgane 162(3): 249-255